Andrew Guggenhime - 18 May 2022 Form 4 Insider Report for Metacrine, Inc. (MTCR)

Role
Director
Signature
/s/ Michael York, Attorney-in-fact
Issuer symbol
MTCR
Transactions as of
18 May 2022
Transactions value $
$0
Form type
4
Date filed
06 Sep 2022, 19:21
Previous filing
20 Apr 2022
Next filing
12 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MTCR Stock Option (right to buy) Award $0 +16.5K $0.00 16.5K 18 May 2022 Common Stock 16.5K $0.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day immediately prior to the date of the Issuer's 2023 annual meeting of stockholders.